BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dell’oglio P, Stabile A, Gandaglia G, Zaffuto E, Fossati N, Bandini M, Suardi N, Karakiewicz PI, Shariat SF, Montorsi F, Briganti A. New surgical approaches for clinically high-risk or metastatic prostate cancer. Expert Review of Anticancer Therapy 2017;17:1013-31. [DOI: 10.1080/14737140.2017.1374858] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Dell'oglio P, Tappero S, Longoni M, Buratto C, Scilipoti P, Secco S, Olivero A, Barbieri M, Palagonia E, Napoli G, Strada E, Petralia G, Di Trapani D, Vanzulli A, Bocciardi AM, Galfano A. Retzius-sparing Robot-assisted Radical Prostatectomy in High-risk Prostate Cancer Patients: Results from a Large Single-institution Series. European Urology Open Science 2022;38:69-78. [DOI: 10.1016/j.euros.2022.02.007] [Reference Citation Analysis]
2 Heidenreich A. [Limits of surgery in uro-oncology]. Urologe A 2018;57:1058-68. [PMID: 30043291 DOI: 10.1007/s00120-018-0735-y] [Reference Citation Analysis]
3 Mijuskovic M, Saunders EJ, Leongamornlert DA, Wakerell S, Whitmore I, Dadaev T, Cieza-Borrella C, Govindasami K, Brook MN, Haiman CA, Conti DV, Eeles RA, Kote-Jarai Z. Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease. Br J Cancer 2018;119:96-104. [PMID: 29915322 DOI: 10.1038/s41416-018-0141-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
4 Rose Dite Modestine J, Neuzillet Y, Herve JM, Bosset PO, Abdou A, Bohin D, Ghoneim T, Rouanne M, Radulescu C, Lebret T. [12-year history of radical surgery indications for the treatment of prostate cancer]. Prog Urol 2019;29:408-15. [PMID: 31280925 DOI: 10.1016/j.purol.2019.06.006] [Reference Citation Analysis]
5 Burns D, Anokian E, Saunders EJ, Bristow RG, Fraser M, Reimand J, Schlomm T, Sauter G, Brors B, Korbel J, Weischenfeldt J, Waszak SM, Corcoran NM, Jung CH, Pope BJ, Hovens CM, Cancel-Tassin G, Cussenot O, Loda M, Sander C, Hayes VM, Dalsgaard Sorensen K, Lu YJ, Hamdy FC, Foster CS, Gnanapragasam V, Butler A, Lynch AG, Massie CE, Woodcock DJ, Cooper CS, Wedge DC, Brewer DS, Kote-Jarai Z, Eeles RA; CR-UK/Prostate Cancer UK, ICGC, The PPCG. Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study. Eur Urol 2022:S0302-2838(22)02341-7. [PMID: 35659150 DOI: 10.1016/j.eururo.2022.05.007] [Reference Citation Analysis]
6 Mazzone E, Dell'Oglio P, Rosiello G, Puliatti S, Brook N, Turri F, Larcher A, Beato S, Andras I, Wisz P, Pandey A, De Groote R, Schatteman P, De Naeyer G, D'Hondt F, Mottrie A. Technical Refinements in Superextended Robot-assisted Radical Prostatectomy for Locally Advanced Prostate Cancer Patients at Multiparametric Magnetic Resonance Imaging. Eur Urol 2021;80:104-12. [PMID: 32943260 DOI: 10.1016/j.eururo.2020.09.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Zhang Q, Cheng H, Wang Y, Tian Y, Xia J, Wang Y, Zhou X, Meng X, Wang Y, Gu M, Song N. Different therapeutic regimens in the treatment of metastatic prostate cancer by performing a Bayesian network meta-analysis. Int J Surg 2019;66:28-36. [PMID: 31002882 DOI: 10.1016/j.ijsu.2019.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]